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Abstract
During normal development oligodendrocyte precursors (OPCs) are generated in the ventral spinal cord in response to
Sonic hedgehog (Shh) signalling. There is also a second, late wave of oligodendrogenesis in the dorsal spinal cord
independent of Shh activity. Two signalling pathways, controlled by bone morphogenetic protein and fibroblast growth
factor (FGF), are active players in dorsal spinal cord specification. In particular, BMP signalling from the roof plate has a
crucial role in setting up dorsal neural identity and its inhibition is sufficient to generate OPCs both in vitro and in vivo. In
contrast, FGF signalling can induce OPC production from dorsal spinal cord cultures in vitro. In this study, we examined the
cross-talk between mitogen-activated protein kinase (MAPK) and BMP signalling in embryonic dorsal spinal cord cultures at
the SMAD1/5/8 (SMAD1) transcription factor level, the main effectors of BMP activity. We have previously shown that FGF2
treatment of neural precursor cells (NPCs) derived from rat E14 dorsal spinal cord is sufficient to generate OPCs in vitro.
Utilising the same system, we now show that FGF prevents BMP-induced nuclear localisation of SMAD1-phosphorylated at
the C-terminus (C-term-pSMAD1). This nuclear exclusion of C-term-pSMAD1 is dependent on MAPK activity and correlates
with OLIG2 upregulation, the obligate transcription factor for oligodendrogenesis. Furthermore, inhibition of the MAPK
pathway abolishes OLIG2 expression. We also show that SMAD4, which acts as a common partner for receptor-regulated
Smads including SMAD1, associates with a Smad binding site in the Olig2 promoter and dissociates from it upon
differentiation. Taken together, these results suggest that FGF can promote OPC generation from embryonic NPCs by
counteracting BMP signalling at the Smad1 transcription factor level and that Smad-containing transcriptional complexes
may be involved in direct regulation of the Olig2 promoter.
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Introduction
The vertebrate brain is composed of a variety of neural cell
types which are generated from neural precursor cells (NPCs) that
have the potential to differentiate into neurons, astrocytes, and
oligodendrocytes [1]. Differentiation of NPCs into neurons and
glia occurs in temporally distinct waves with neurogenesis
preceding gliogenesis [2]. The origin of oligodendrocytes, the
myelinating cells of the vertebrate central nervous system (CNS),
has been studied extensively in the developing spinal cord and two
distinct phases of oligodendrogenesis have been established. OPCs
first originate from the motor neuron progenitor (pMN) domain of
the ventral neural tube under the influence of Shh signalling from
the notochord and floorplate [3,4]. In addition Shh has been
implicated in the proliferation, maintenance and migration of
adult neural precursors and their derivatives [5–8]. The ventrally-
derived OPCs migrate laterally and dorsally, populating the CNS
before maturing into myelin-forming oligodendrocytes. A second
phase of oligodendrogenesis takes place in the embryonic dorsal
spinal cord (DSC) which is independent of Shh signalling [9,10].
Using in vitro systems, it has been shown that Shh signalling is not
essential for oligodendrogenesis as NPCs isolated from the
embryonic spinal cord can generate oligodendrocytes in the
presence of cyclopamine-KAAD (a potent blocker of hh signalling)
[11,12]. In addition, oligodendrocytes may still be produced by
NPCs isolated from Shh functional knockout mice [12]. Later
studies by Cai et al. (2005) and Vallstedt et al. (2005) confirmed
that in vivo, oligodendrocytes originate in the developing DSC as
well as in the ventral pMN domain.
The BMPs are members of the TGF-b family and are known
inhibitors of neuronal differentiation [13]. In addition, BMP
signalling is known to inhibit Shh-induced oligodendrogenesis and
it has been shown that inhibition of BMP signalling is sufficient to
induce oligodendrocyte generation both in vitro and in vivo
[9,14,15]. BMPs are secreted signalling proteins that bind to
cell-surface serine/threonine kinase receptors [16]. Activated
receptor kinases in turn relay this signal to the nucleus via
activation of Smad transcription factors, which is achieved by
phosphorylation of the C-terminal SXS motif [17]. There are five
mammalian receptor-regulated Smads (R-Smads) (Smads 1–3, 5
and 8) that serve as substrates for the TGF-b receptor family.
Smads 1, 5, and 8 are targets for BMP and anti-Mullerian
receptors, whereas Smads 2 and 3 are regulated by TGF-b, Nodal
and activin receptors [17,18]. In addition to receptor-mediated
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activation the formation of transcriptionally active Smad com-
plexes also requires dimerisation of R-Smads with SMAD4, also
referred as Co-Smad [17]. R-Smad/SMAD4 oligomers form the
core of diverse multi-subunit transcriptional regulation complexes,
which include other DNA sequence-specific binding proteins and
co-factors. Altogether the combination of these factors determine
target specificity, leading to activation or repression of certain
genes [17].
Two bHLH transcription factors, Olig1 and Olig2, are also
known to regulate oligodendrocyte specification in the developing
nervous system [19–23]. Specifically, Olig2 is an obligate factor for
oligodendrogenesis in the developing spinal cord as the disruption
of Olig2 alone results in complete elimination of oligodendrocytes
[19,20]. Regulation of Olig1 and Olig2 expression presents a key
step in oligodendrocyte differentiation and two signalling path-
ways, MAPK and BMP, are known to play opposing roles in this
process. BMP mediated signalling blocks dorsal oligodendrocyte
specification in vitro, and their generation is promoted when BMP
signalling is inhibited [12]. Indeed, production of OLIG2+
dorsally-derived OPCs which arise later than their ventral
counterparts correlates with a decrease in BMP signalling [9,10].
In contrast, FGF signalling has been shown to promote Olig2
expression and oligodendrocyte differentiation in vitro [11,12] via
MAPK signalling, including in dorsal explants [10]. Furthermore,
exposure of dorsal PAX7+ cells to a FGF receptor antagonist
abolishes any OLIG2 expression [9] indicating that FGF activity is
required for oligodendrogenesis in the DSC.
BMP-regulated Smads lie at the crossroads of the antagonistic
signalling interplay between MAPK and BMP pathways. BMP
receptor kinases relay signals through C-terminal phosphorylation
and nuclear translocation of the transcription factor SMAD1,
whereas MAPKs catalyse inhibitory phosphorylation in the
SMAD1 linker region that results in the cytoplasmic sequestration
of SMAD1 [17,18,24,25]. Recently, the regulation of SMAD1
activity has been elucidated in detail revealing interplay of MAPK,
Smurf1 and nucleoporin interactions that control the cytoplasmic
sequestration and turnover of SMAD1 protein [26].
Here, we show that BMP signalling pathway is active in rat
embryonic DSC precursor cultures and that the MAPK pathway
is responsive to FGF2 treatment. We also show that BMP-
activated SMAD1, that is C-term-pSMAD1, is sequestered in the
cytoplasm in a MAPK-dependent manner accompanied with
increased OLIG2 expression suggesting that FGF2 can potentially
antagonise BMP signalling in the embryonic DSC during
oligodendrogenesis. SMAD4, which is also referred as Co-Smad
due to its dimerisation with R-Smads, associates with the Olig2
promoter in undifferentiated cells and this interaction is lost upon
induction of Olig2 transcription suggesting that BMP signalling
may directly regulate Olig2 expression.
Results
Smad expression and MAPK signalling activity in DSC
precursor cultures
We and others have shown that FGF2 can induce Shh-
independent production of oligodendrocytes by dissociated NPCs
and in dorsal explants [10,11]. FGFs, through binding to their
cognate receptors, activate several signal transduction cascades
including the extracellular signal-regulated protein kinase (ERK)
cascade which is part of the canonical MAPK pathway [27].
MAPK pathway activators counterbalance BMP action during
neurogenesis, bone formation, and other aspects of vertebrate
development. BMP receptors signal through C-terminal phos-
phorylation and nuclear translocation of the transcription factor
SMAD1, whereas MAPK catalyses inhibitory phosphorylation in
the SMAD1 linker region. To determine if such a mechanism of
action is responsible for FGF2 dependent oligodendrogenesis from
rodent dorsal cord, we established primary cultures of DSC NPCs
from E14 embryos, at which point there are no constitutive dorsal
OPCs [12,28].
First, we established the expression pattern of the downstream
effectors of BMP signalling in our culture system. Semi-
quantitative RT-PCR expression analysis of Smad 1, 5, and 8
revealed that Smad1 and Smad5 were expressed at high levels
whereas Smad8 transcript levels were much lower (Figure 1A,
compare cycle numbers 26 and 30 for Gapdh, Smad1/5/8). All
three transcripts were readily detected in total E14 trunk cDNA at
cycle 30. These results showed that there is preferential expression
of Smad1 and Smad5 in the E14 rat dorsal spinal cord.
We next examined the MAPK pathway activity in different
DSC culture conditions. Primary DSC precursor cells were
cultured for 12 hours after isolation and were subsequently treated
for 6 hours with FGF2, FGF2+U0126 (an inhibitor of MAPK
signalling), BMP4 or DMSO (control). Western blotting using an
antibody to phospho-ERK1/2, specific for the active form of the
enzyme, enabling assessment of MAPK activity, was next
undertaken. A low level of MAPK activity in DSC cells was
detected under control and BMP4-treated conditions (Figure 1B).
Treatment of DSC precursor cultures with FGF2, however,
resulted in robust activation of MAPK signalling pathway as
judged by increased levels of phospho-ERK1/2. This effect was
reduced in the presence of U0126 (Figure 1B). These results are
consistent with the absence of strong, sustained MAPK activity in
dissociated DSC cultures and further that MAPK signal
transduction pathway is responsive to stimulation by FGF2
treatment.
FGF2 induces OLIG2+ cells
Following confirmation of very low numbers of OLIG2+ cells
(Figure 1C and 1D, control 6h 0.4560.12%) in primary DSC
cultures, we next examined whether FGF2 treatment results in
upregulation of OLIG2 expression. Addition of BMP4 did not
significantly influence OLIG2+ cells (Fig 1C and 1D). However,
treatment with FGF2 resulted in a substantial increase in numbers
of OLIG2+ cells; 1.4660.26% and 6.2561.00% after 24 and
72 hours, respectively and was significant compared to control and
BMP4 treated cultures (Fig 1C and 1D). Co-treatment with
MAPK inhibitor U0126 and FGF2 resulted in a negligible
increase in OLIG2+ cells indicating FGF2-induced OLIG2
expression is MAPK signalling dependent (Figure 1D). To
investigate whether increased BMP signalling can antagonise
induction of OLIG2 expression by FGF2, primary DSC cultures
were co-treated with FGF2 and BMP4 for 72 hours. The number
of OLIG2+ cells was reduced by 60.75% compared to FGF2 only
(p,0.01) suggesting that BMP signalling can directly compete with
the effects of FGF2.
FGF2 regulates sub-cellular localisation of SMAD1
Receptor-mediated phosphorylation of Smad factors at the C-
terminus (C-term-pSmad) results in their nuclear accumulation,
ultimately converting the BMP signal to a transcriptional readout.
To analyse the subcellular localisation of C-term-pSMAD1 in
response to different growth conditions, dissociated cells were
grown in the presence or absence of FGF2 (as shown in Figure 1B)
for different periods of time and the localisation of C-term-
pSMAD1 examined using immunocytochemistry. Under control
conditions, when BMP signalling was active, C-term-pSMAD1
was predominantly nuclear (Figure 2A). Addition of BMP4
FGF and BMP Signalling in OPCs
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resulted in a near exclusive nuclear localisation (Figure 2A). FGF2
treatment for 6 hours resulted in nuclear exclusion of C-term-
pSMAD1. To test if the effect of FGF2 on C-term-pSMAD1
localisation was due to MAPK activity, the specific MEK inhibitor
U0126 was added to DSC cultures. Addition of U0126 together
with FGF2 abolished the cytoplasmic sequestration/nuclear
exclusion of C-term-pSMAD1 (Figure 2A and 2B) showing that
C-term-pSMAD1 requires MAPK signalling for its nucleo-
cytoplasmic shuttling.
It has previously been shown that deactivation of SMAD1
requires phosphorylation at the linker region by the MAPK
pathway [24,25] and that this linker phosphorylation event can
result in cytoplasmic retention of SMAD1 [25]. There are four
MAPK phosphorylation sites conserved between linker regions of
Smad1, 5 and 8 in humans [26]. To investigate if there was a
change in linker-phosphorylated SMAD1 (L-pSMAD1) levels in
response to FGF2 treatment, we repeated the earlier experiment
with analysis of L-pSMAD1 expression. The polyclonal antibody
used to detect L-pSMAD1 was raised against the fourth MAPK
phosphorylation site in the linker region of hSMAD1 (Figure 2C)
[29]. Amino acid sequence alignment between the linker regions of
human SMAD1 and rat SMAD1, 5 and 8 proteins showed that
the fourth MAPK phosphorylation site, and the antigen used for
immunisation, is identical between human and rat Smad1
orthologues (Figure 2C, [29]). Sequence alignment also revealed
that the fourth phosphorylation site was conserved in Smad5 but
was not present in Smad8 suggesting that L-pSMAD1 antibody is
likely to recognise both linker-phosphorylated rat Smad1 and
Smad5 paralogues. Upon FGF2 treatment, cytoplasmic L-
pSMAD1 levels increased and was clearly visible in cytoplasmic
processes of some cells (Figure 2D, compare control and FGF2
treated). Furthermore, BMP4 treatment did not effect the basal
level of L-pSMAD1 as detected by immunofluorescence
(Figure 2D) and the quantification of cytoplasmic/nuclear L-
pSMAD1 signal ratios showed that FGF2 treatment resulted in
73% increase in L-pSMAD1 levels in the cytoplasm compared to
BMP4 (Figure 2E, relative cytoplasmic/nuclear signal intensity:
FGF2 1.335 +/2 0.156, BMP4 0.71 +/2 0.23, p,0.05, paired T-
test). Taken together, these data suggest that FGF2 treatment can
antagonise BMP signalling by regulating the subcellular localisa-
tion of SMAD1 via the MAPK pathway in dissociated rat
embryonic DSC cultures and that OLIG2 expression correlates
with nuclear exclusion of C-term-pSMAD1. Since Shh and FGF2
signaling provide independent mechanisms of inducing Olig2
Figure 1. Smad expression, MAPK signalling analysis and quantification of OLIG2 expressing cells in DSC neural precursor cell
cultures. A. Semi-quantitative RT-PCR analysis of Smad1, 5, and 8 expression in primary E14 rat dorsal spinal cord cultures. Rat E14 trunk cDNA was
used as positive control. B. Western blot analysis of extracts from different DSC culture conditions using anti-phospho ERK1/2 polyclonal antibody to
assess MAPK activity. Anti-ERK2 antibody was used as a loading control. C. Primary cultures of E14 dorsal neural precursor cells were treated with
FGF2, BMP4 or FGF2+U0126 for 6, 24 or 72 hours and stained for OLIG2 expression. Pictographs showing representative fields for different culture
conditions after 72 hours of treatment. D. Cells expressing OLIG2 were counted and represented as percent of the total cell number. Data represent
mean +/2 SEM. FGF2 treatment 72 h time point is statistically different from 6 and 24 h (ANOVA with Tukey HSD test, p,0.01). FGF2 treatment is
also statistically different at each time point compared to other conditions (*,p,0.05; **, p,0.0001; *** p,0.0001; ANOVA with Tukey HSD).
doi:10.1371/journal.pone.0002863.g001
FGF and BMP Signalling in OPCs
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expression and oligodendrogenesis [14,15] one possibility would
be for activated-SMAD subcellular localisation to provide a point
of cross-talk between the two pathways. However, analysis of Shh
treated rat DSC cells did not result in any significant subcellular
localisation change of C-term-pSMAD1 (result not shown)
suggesting that SMAD signalling does not provide a point of
cross-talk between the two pathways.
SMAD4 associates with Smad binding sites in Olig2
promoter
Olig2 is a bHLH transcription factor with a critical role in both
motor neuron and oligodendrocyte specification. Its expression is
regulated both temporally and spatially during neural develop-
ment [19,30,31] . However, the promoter of the Olig2 gene is not
described in the literature and there is limited information on
trans-acting factors that regulate its expression. Recently, using
mouse embryonic stem (mES) cells as a model for analysing neural
gene transcription it was shown that Olig2 has a complex promoter
structure with a 2 kb proximal region that contributes significantly
to promoter activity [32]. In mES cells BMP4 acts in combination
with LIF to sustain self-renewal and preserve multilineage
differentiation potential [33]. To investigate if BMP4 signalling
can potentially regulate Olig2 expression via Smads undifferenti-
ated mES cells were studied. Undifferentiated mES cells do not
express Olig2 as determined by semi-quantitative RT-PCR
(Figure 3A) but can be induced, in defined conditions, upon
addition of FGF2 or with combinatorial application of FGF2,
retinoic acid and Shh during directed differentiation of mES cells
Figure 2. FGF2 regulates sub-cellular localisation of SMAD1. A. Primary cultures of E14 dorsal neural precursor cells were treated with FGF2,
BMP4 or FGF2+U0126 for 6 hours or 24 hours and labelled for C-term-pSMAD1. Representative fields from 6 hours treatment is shown. B. Cells
showing an exclusive nuclear or an exclusive cytoplasmic localisation were counted and are represented as a percent of total C-term-pSMAD1
expressing cells. Data represent mean +/2 SEM. FGF2 treatment at each time point is statistically different from the three other groups (ANOVA and t-
Test with Bonferonni, p,0.001). C. Alignment of the linker regions of receptor-regulated Smads and identification of MAPK phosphorylation sites.
Conserved phosphorylation motifs between human SMAD1 and rat SMADs are highlighted in grey; green marking the peptide L-pSMAD1 antibody is
raised against. D. Primary cultures of E14 dorsal neural precursor cells were treated with FGF2, or BMP4 for 6 hours and stained for L-pSMAD1.
Representative fields are shown. E. Comparison of L-pSMAD1 cytoplasmic/nuclear signal levels between FGF2 and BMP4 treated samples. Data
represent mean +/2 SEM (p,0.05, paired T-test).
doi:10.1371/journal.pone.0002863.g002
FGF and BMP Signalling in OPCs
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to motor neurons (Figure 3A) [34,35]. Putative Smad binding sites
were determined in the 4 kb upstream sequence from the
transcription start site of mouse Olig2 using MatInspector and
rVista2 [36,37]. Four sites which are conserved between mouse
and rat were chosen to be studied for in vivo SMAD4 association
using chromatin immunoprecipitation. SMAD4 was chosen on the
basis that all Smad transcriptional complexes identified to date
contain SMAD4 [17]. Our results indicate that Smad4 binds
specifically to one of these promoter elements in undifferentiated
mES cells (Figure 3B, BS3). Interestingly, upon directed
differentiation of mES cells towards motor neurons, with
concomitant high Olig2 expression (Figure 3A, d8 F/R/S lane),
SMAD4 occupancy at BS3 is no longer detectable with ChIP
(Figure 3B) suggesting that SMAD4 containing complexes may
directly regulate the Olig2 promoter.
Discussion
Fate specification and differentiation requires the interplay of
multiple developmental signals. We provide evidence using a well
characterised developmental model that dorsal cord induction of
Olig2 is dependent on MAPK activity that antagonises BMP
mediated signalling resulting in cytoplasmic sequestering of C-
term-pSMAD1. Furthermore, we provide evidence that SMAD4,
a common partner for receptor-regulated Smads including
SMAD1, associates with a Smad binding site in the Olig2
promoter with subsequent dissociation upon differentiation.
In general, it is believed that BMP signalling prevents neuronal
differentiation. However, in dissociated Xenopus embryonic ecto-
dermal cells sustained MAPK activity causes neuronal differenti-
ation despite the presence of BMP signalling, showing that MAPK
signalling can counteract the BMP pathway [29]. Our results show
that BMP signalling is intact in dissociated rat embryonic DSC
cultures, where the transcription factors Smad1 and Smad5 are
transcribed highly and BMP receptor kinase-activated SMAD1,
C-term-pSMAD1, is present. However, there is no strong and
sustained MAPK activity in embryonic DSC cultures, demon-
strated by very low levels of activated ERK1/2 in control
conditions, in contrast to Xenopus embryonic ectodermal cells
[29]. Nevertheless, treatment with FGF2 resulted in activation of
the MAPK pathway revealing that DSC derived NPCs are
responsive to MAPK activators. Further experiments are needed
to determine which FGF receptors are present on precursor cells.
Developmental origin of oligodendrocytes has been an area of
much study. In addition to early restricted ventral foci of OPCs,
recent studies have determined a second dorsal wave of
oligodendrogenesis both in the spinal cord and forebrain
[9,10,38]. The early ventral phase of spinal cord oligodendrogen-
esis originates in the pMN domain. The second dorsal derived
wave, in contrast to oligodendrocyte generation in the ventral
neural tube, is independent of Shh-signalling [10–12]. It is
suggested that oligodendrogenesis in the developing dorsal neural
tube results from integration of FGF signalling and decreasing
BMP action in the region [9,10]. Recent work on mouse
mesencyhmal progenitor cells and neuroectodermal explants in
Xenopus has elucidated, at the molecular level, how MAPK
signalling can oppose BMP activity via the SMAD1 transcription
factor. Signalling events triggered by different factors such as
FGF8, IGF2, JNK and p38 can all lead to linker-phosphorylation
of SMAD1 via MAPK pathway activity [24–26]. This in turn
leads to degradation of SMAD1 via the proteasome [26] and/or
cytoplasmic retention of the protein [26,39]. The nuclear
exclusion and degradation of SMAD1 are not mutually exclusive
events as the binding of SMURF1 to SMAD1, which leads to
SMAD1 polyubiquitination also inhibits the interaction of
SMAD1 with the nuclear pore complex [26]. Our results suggest
that FGF signalling can directly counteract BMP action in DSC
precursor cells by regulating the subcellular localisation of BMP
receptor-kinase activated SMAD1 (C-term-pSMAD1). The tran-
scriptionally active form of SMAD1, C-term-pSMAD1, is
predominantly nuclear under control conditions where there is
ongoing BMP signalling. Receptor-regulated Smads undergo
continuous nucleo-cytoplasmic shuttling enabling them to respond
to changing stimuli [17]. We report that treatment of DSC
precursor cultures with FGF2 activates the MAPK pathway and
results in rapid cytoplasmic sequestration of C-term-pSMAD1,
thereby inhibiting BMP signalling. Concomitantly, linker-phos-
phorylated SMAD1 (L-pSMAD1) levels were observed to increase
in the cytoplasm. Furthermore, the basal level of cytoplasmic L-
Figure 3. SMAD4, co-partner for all Receptor-Smads, binds to Olig2 promoter. A. Semi-quantitative RT-PCR analysis of Olig2 expression in
undifferentiated (control) and neuralised (FGF2 only and FGF2/Shh/Retinoic Acid (F/S/R)) W9.5 mES cells. mES cells neuralised in chemically defined
medium (CDM) for 4 days were further differentiated for 4 days in CDM+FGF2 (d8 FGF) or CDM+F/S/R (d8 F/S/R). Olig2 transcription is not detected in
undifferentiated mES cells but is strongly induced upon 4 day differentiation in FGF2/Shh/Retinoic Acid containing medium. B. Schematic
representation of putative Smad binding sites (BS) targeted for analysis in 4 kb promoter region of Olig2. PCR products identified by agarose gel
electrophoresis after chromatin immunoprecipitation from W9.5 mES cells with Smad4 antibody. Smad4 binding was detected at BS3 only. No Smad4
binding is detected using beads only or at 39 UTR of Olig2. Smad4 binding at BS3 site is lost upon differentiation. Nucleotides represented in
uppercase are exact matches to previously described consensus binding sequences at respective Smad sites in the Olig2 promoter. The positions of
the binding sites are shown relative to the transcription start site.
doi:10.1371/journal.pone.0002863.g003
FGF and BMP Signalling in OPCs
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pSMAD1 signal observed in cells under BMP and control
conditions suggest a continuous turn-over of the Smad1 protein
in DSC neural precursor cells.
Oligodendrogenesis in the CNS is regulated by two bHLH
transcription factors, Olig1 and Olig2 [19–21,30]. Treatment of
DSC precursor cells with FGF2 resulted in significant and rapid
increase in numbers of OLIG2+ cells that correlated with the de-
activation/cytoplasmic sequestration of SMAD1. One outstanding
question is whether the Olig2 promoter is regulated by Smads
directly. Recent developments of detailed differentiation protocols
for neural cells from mES cells provide a valuable platform to
study the regulation of neural gene transcription. ES cell
differentiation in vitro is thought to recapitulate in vivo develop-
mental programmes [40–43]. In mES cells BMP4 acts in
combination with LIF to sustain self-renewal and preserve
multilineage differentiation, chimera colonisation, and germline
transmission properties. A critical contribution of BMP4 is to
induce expression of Id genes via the Smad pathway, which
suppresses differentiation to neural lineages [33]. Our ChIP results
show that SMAD4, also known as Co-Smad, can associate with
the Olig2 promoter in undifferentiated mES cells. Moreover, upon
induction of Olig2 expression in mES cells during motor neuron
differentiation SMAD4 is displaced from the BS3 site on the Olig2
promoter suggesting that BMP signalling may directly regulate the
expression of Olig2. Recently it was shown that the conditional
deletion of Smad4 in the adult mouse subependymal zone resulted
in elevated expression of OLIG2, implicating SMAD4 containing
complexes in the modulation of Olig2 expression [44]. Upon
activation by phosphorylation, receptor-regulated Smads (Smad1/
5/8 in the case of BMP signalling) dimerise with SMAD4 and
assemble multi-protein transcription regulatory complexes that
target several promoters for activation or repression [17]. For
instance, the transcriptional repressor Nkx3.2, which can induce
chondrocyte differentiation in the presence of BMP signalling [45],
forms a complex with SMAD1/SMAD4 and mSin3/HDAC co-
repressor complex demonstrating that BMP-activated Smads can
be involved in transcriptional repression [46]. It is thus plausible
that BMP signalling assembles a SMAD-dependent transcriptional
repression complex on the Olig2 promoter and that FGF2
signalling via MAPK activity relieves this repression by sequester-
ing SMAD1 in the cytoplasm. The presence of multiple highly
homologous receptor-regulated Smads in tissues, as in the high
level expression of Smad1 and Smad5 in DSC precursor cells, raises
the possibility of functional redundancy among the transcription
factor family. Further functional studies are required to investigate
Olig2 promoter structure, contribution of the putative Smad
binding sites to the promoter activity along with the associated
Smads and the composition of the transcriptional regulation
complexes that may target these sites.
Materials and Methods
Primary and mES cell culture
The care and treatment of the animals used in this study was in
accordance with UK Home Office and University of Cambridge
regulations. Primary rat DSC cultures were performed as
previously described [12]. Briefly, spinal cords were dissected out
from embryonic day 14 Sprague Dawley rats (Charles River
Laboratories, U.K.). Only the dorsal columns were collected. The
tissue was dissociated in 0.1% trypsin (Sigma, U.K.) for 15 min at
37uC and after addition of DNase (0.001%, Sigma, U.K.) and
centrifugation at 1,000 g for 3 min, cells were platted on poly-d-
lysine coverslips at 50,000 cells/well in 6 wells plates and grown in
Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, Invitrogen,
U.K.) containing 2% B27 supplements (Gibco. Invitrogen, U.K.)
and 1% penicillin/streptomycin and amphotericin (PSF, Sigma,
U.K.) at 37uC in 5% CO2. When tested, growth factors were
added after an overnight culture at the following concentrations:
FGF2 20 ng/ml (R&D Systems Inc.), BMP4 10 ng/ml (R&D
Systems Inc.) and U0126 10 mM. Cells were grown for 6 to 72 h
before analysis. W9.5 mES cell line was maintained and neuralised
as explained in detail in Bouhon et al., (2006). Briefly,
enzymatically dissociated mES cells were resuspended in chem-
ically defined medium (CDM) and plated at 16105 cells per ml in
10-cm bacteriological grade culture dishes. Cultures were passaged
by dissociating spheres by mechanical trituration. At day 4,
cultures were treated with either FGF2 (control) or FGF2/Shh/
Retinoic acid (neuralisation) for 4 more days. Growth factors were
used at the following concentrations: fibroblast growth factor 2
(FGF2), 20 ng/ml (R&D Systems Inc.); Sonic hedgehog N-
terminal peptide (SHH-N), 250 ng/ml (R&D Systems Inc.); all-
trans-retinoic acid (RA), 1 mM (Sigma-Aldrich).
Immunocytochemistry
After 6, 24, or 72 h in culture, cells were washed with PBS and
fixed 5 min with 4% paraformaldehyde. For C-term-pSMAD1
staining, cells were washed 3 times with PBS and permeabilized
with ice-cold methanol for 10 min at220uC. After blocking in 10%
normal goat serum (NGS) in PBS containing 0.05% Triton X100
for 1 h, cells were incubated overnight at 4uC with anti-pSMAD1/
5/8 antibody (Cell Signaling Technologies, U.S.A., Cat no: 9511S,
phosphoSmad1/5/8 (Ser 463/465, Ser 426/428, Ser 463/465))
diluted 1:100 in PBS containing 2% NGS and 0.05% Triton X100.
After three washes in PBS, goat anti-rabbit antibody coupled to
biotin (Molecular Probes, Invitrogen ,1:200 in PBS) was applied for
1 h at room temperature then FITC-coupled streptavidin (Molec-
ular Probes, Invitrogen ,1:200 in PBS) and Hoescht (Sigma, 1:5000
in PBS) were applied for 1 hour at room temperature. For Olig2
staining, cells were washed 3 times with PBS, blocked in PBS/10%
NGS/0.05%Triton X100 for 1 h, and incubated overnight at room
temperature with anti-Olig2 antibody (gift from Dr. Takeyabashi)
diluted 1:3,000 in 2%NGS/PBS/0.05% Triton X100. After three
washes in PBS, goat anti-rabbit coupled to Alexa 488 (Molecular
Probes, Invitrogen, 1:500 in PBS) was applied for 1 h at room
temperature together with Hoescht (Sigma, 1:5000). L-pSMAD1
polyclonal antibody was kindly provided by Dr. De Robertis and
was used at 1:5000 following standard protocols [29]. Coverslips
were mounted in Vectashield mounting medium (Vectra Labora-
tories, U.K.)
Quantification and statistical analysis
Immunofluorescence was observed under a Leitz microscope at
high magnification (640) and at least 5 fields/coverslips, 2
coverslips/experiment from at least 3 different experiments
(n = 5 for Olig2 quantification) were taken into pictures for
quantification. For Olig2 staining, the number of positive cells as
well as the total number of cells were counted. C-term-pSMAD1
staining was counted in the different cellular compartments and
total cell number was assessed. The mean value of the 2 coverslips
of each experiment was used to calculate the average and the
standard error between the different experiments. The significance
of the different treatments on C-term-pSMAD1 localisation and
on Olig2 expression were assessed by one-way analysis of variance
(ANOVA) followed by Tukey HSD test or t-Test with Bonferoni
correction, as indicated in the text. Cytoplasmic/nuclear L-
pSMAD1 levels were quantified using ImageJ software with MRI
Cell Image Analyzer plugin, averaged over 4 random fields/
experiment from 4 different experiments.
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Immunoblotting
Immunoblotting was carried out according to standard
procedures. Protein samples were subjected to electrophoresis on
denaturing 10% polyacrylamide gels, which were then transferred
to PVDL membranes (Immobilon-P, Millipore) and analyzed by
Western blotting. The proteins were detected with ECL reagent
(GE Healthcare) in conjunction with appropriate horseradish
peroxidase coupled secondary antibodies (BioRad). The antibodies
used were rabbit polyclonal anti-ERK2 (Santa-Cruz SC-154) and
anti-phospho p44/42 MAPK (Thr 202/Tyr204) (Cell Signaling
Technologies 9101S).
RNA Isolation and RT-PCR
Total cellular RNA was extracted from primary rat DSC
cultures or undifferentiated or neuralised W9.5 mES cells using
the RNeasy Mini isolation kit (Qiagen). RNase-free-DNase (New
England Biolabs) treated RNA samples (2 mg) were reverse
transcribed in 100 ml with random hexamers using MMLV RT
(Invitrogen) according to manufacturer’s protocol. PCR was
conducted in 25 ml reaction volume using 2 ml cDNA synthesised
as described above with BioTaq polymerase (BioLine). The
primers used were: mouse hypoxanthine phosphoribosyl-transfer-
ase (mHPRT) forward:
59-AGCTACTGTAATGATCAGTCAACG-39;
mHPRT reverse: 59- AGAGGTCCTTTTCACCAGCA-39;
mOlig2 forward: 59-GTGGCTTCAAGTCATCTTCC-39;
mOlig2 reverse: 59-GTAGATCTCGCTCACCAGTC-39;
rat Smad1 forward: 59- GGCCAGCCGCTATGAATGTGA-39;
rSmad1 reverse: 59-TGGGAACTCGCAGCATTCCAG-39;
rSmad5 forward: 59- GGCTCTGACGATTCGTATCAA-39;
rSmad5 reverse: 59- AGGAAACTCACAAATATCCAA-39;
rSmad8 forward: 59- TCCGAGTCAGACAGTCCTTAT-39;
rSmad8 reverse: 59- GTACAAATGCACACCCTTTCC-39;
rGAPDH forward: 59-TTCCAGTATGACTCTACCC-39;
rGAPDH reverse: 59-ATGGACTGTGGTCATGAGCCC-39.
To compensate for variable RNA and cDNA yields, the expression
of HPRT was used as a control in mES experiments for which the
optimal number of PCR cycles for linear amplification was
determined. The amplification products were analyzed by agarose
gel electrophoresis.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was carried out with poly-
clonal Smad4 antibody (Santa Cruz Biotechnology, SC-7154X)
using a modified protocol (PROT11) which can be found at
http://www.epigenome-noe.net/researchtools/protocol.php?pro-
tid = 10. Smad binding sites were identified using MatInspector
and rVista2 [36,37]. Primers were designed to encompass the
selected sites (see Figure 3B for details) as follows:
BS2 forward: 59-TAGTCCTTGCACAATTGCGT-39;
BS2 reverse 59-AAGCCAGAAGGACTGTAGAATGG-39;
BS3 forward: 59-ACCTATCTCCCGCATATTGTACC-39;
BS3 reverse: 59-GACCCATAACCGTTCAATTAGC-39;
BS4 forward: 59-ATAAATATCCCAACAAACAAACA-39;
BS4 reverse: 59-AATTCCTAGGTTTTCACTTCCATAA-39;
BS5 forward: 59-CCTCCTCCCATCCCTCCTCGC-39;
BS5 reverse: 59- GGTTCCGCTGGTTTTTATAGC-39;
Olig2 39UTR forward: 59- ATTGGTTTCTTACCCGAC-
TGG-39;
Olig2 39 UTR reverse: 59-GGAGTCACGTGAACAAAG-
AGC-39.
Acknowledgments
The authors thank Dr De Robertis for the generous donation of the linker-
phospho-Smad antibody. We would also like to thank Natalie Bull and
Sharon Prince for critical reading of the manuscript.
Author Contributions
Conceived and designed the experiments: BB CFH AC NDA SC.
Performed the experiments: BB CFH. Analyzed the data: BB CFH. Wrote
the paper: BB CFH.
References
1. Gotz M, Huttner WB (2005) The cell biology of neurogenesis. Nat Rev Mol Cell
Biol 6: 777–788.
2. Richardson WD, Kessaris N, Pringle N (2006) Oligodendrocyte wars. Nat Rev
Neurosci 7: 11–18.
3. Pringle NP, Yu WP, Howell M, Colvin JS, Ornitz DM, et al. (2003) Fgfr3
expression by astrocytes and their precursors: evidence that astrocytes and
oligodendrocytes originate in distinct neuroepithelial domains. Development
130: 93–102.
4. Orentas DM, Hayes JE, Dyer KL, Miller RH (1999) Sonic hedgehog signaling is
required during the appearance of spinal cord oligodendrocyte precursors.
Development 126: 2419–2429.
5. Loulier K, Ruat M, Traiffort E (2006) Increase of proliferating oligodendroglial
progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral
ventricle. J Neurochem 98: 530–542.
6. Bambakidis NC, Miller RH (2004) Transplantation of oligodendrocyte
precursors and sonic hedgehog results in improved function and white matter
sparing in the spinal cords of adult rats after contusion. Spine J 4: 16–26.
7. Merchan P, Bribian A, Sanchez-Camacho C, Lezameta M, Bovolenta P, et al.
(2007) Sonic hedgehog promotes the migration and proliferation of optic nerve
oligodendrocyte precursors. Mol Cell Neurosci 36: 355–368.
8. Palma V, Lim DA, Dahmane N, Sanchez P, Brionne TC, et al. (2005) Sonic
hedgehog controls stem cell behavior in the postnatal and adult brain.
Development 132: 335–344.
9. Vallstedt A, Klos JM, Ericson J (2005) Multiple dorsoventral origins of
oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45: 55–67.
10. Cai J, Qi Y, Hu X, Tan M, Liu Z, et al. (2005) Generation of oligodendrocyte
precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation
and Shh signaling. Neuron 45: 41–53.
11. Kessaris N, Jamen F, Rubin LL, Richardson WD (2004) Cooperation between
sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in
neocortical precursors. Development 131: 1289–1298.
12. Chandran S, Kato H, Gerreli D, Compston A, Svendsen CN, et al. (2003) FGF-
dependent generation of oligodendrocytes by a hedgehog-independent pathway.
Development 130: 6599–6609.
13. Munoz-Sanjuan I, Brivanlou AH (2002) Neural induction, the default model and
embryonic stem cells. Nat Rev Neurosci 3: 271–280.
14. Miller RH, Dinsio K, Wang R, Geertman R, Maier CE, et al. (2004) Patterning
of spinal cord oligodendrocyte development by dorsally derived BMP4.
J Neurosci Res 76: 9–19.
15. Mekki-Dauriac S, Agius E, Kan P, Cochard P (2002) Bone morphogenetic
proteins negatively control oligodendrocyte precursor specification in the chick
spinal cord. Development 129: 5117–5130.
16. Attisano L, Tuen Lee-Hoeflich S (2001) The Smads. Genome Biol 2:
REVIEWS3010.
17. Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev
19: 2783–2810.
18. Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580:
2811–2820.
19. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, et al. (2000) Sonic hedgehog–
regulated oligodendrocyte lineage genes encoding bHLH proteins in the
mammalian central nervous system. Neuron 25: 317–329.
20. Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, et al. (2000)
Dynamic expression of basic helix-loop-helix Olig family members: implication
of Olig2 in neuron and oligodendrocyte differentiation and identification of a
new member, Olig3. Mech Dev 99: 143–148.
21. Tekki-Kessaris N, Woodruff R, Hall AC, Gaffield W, Kimura S, et al. (2001)
Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon.
Development 128: 2545–2554.
22. Schmiesing JA, Gregson HC, Zhou S, Yokomori K (2000) A human condensin
complex containing hCAP-C-hCAP-E and CNAP1, a homolog of Xenopus
XCAP-D2, colocalizes with phosphorylated histone H3 during the early stage of
mitotic chromosome condensation. Mol Cell Biol 20: 6996–7006.
FGF and BMP Signalling in OPCs
PLoS ONE | www.plosone.org 7 August 2008 | Volume 3 | Issue 8 | e2863
23. Woodruff RH, Tekki-Kessaris N, Stiles CD, Rowitch DH, Richardson WD
(2001) Oligodendrocyte development in the spinal cord and telencephalon:
common themes and new perspectives. Int J Dev Neurosci 19: 379–385.
24. Pera EM, Ikeda A, Eivers E, De Robertis EM (2003) Integration of IGF, FGF,
and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes
Dev 17: 3023–3028.
25. Kretzschmar M, Doody J, Massague J (1997) Opposing BMP and EGF
signalling pathways converge on the TGF-beta family mediator Smad1. Nature
389: 618–622.
26. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J (2007)
Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol
Cell 25: 441–454.
27. Tsang M, Dawid IB (2004) Promotion and attenuation of FGF signaling through
the Ras-MAPK pathway. Sci STKE 2004: pe17.
28. Warf BC, Fok-Seang J, Miller RH (1991) Evidence for the ventral origin of
oligodendrocyte precursors in the rat spinal cord. J Neurosci 11: 2477–2488.
29. Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM (2005) Default
neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/
MAPK activation. Genes Dev 19: 1022–1027.
30. Zhou Q, Wang S, Anderson DJ (2000) Identification of a novel family of
oligodendrocyte lineage-specific basic helix-loop-helix transcription factors.
Neuron 25: 331–343.
31. Zhou Q, Choi G, Anderson DJ (2001) The bHLH transcription factor Olig2
promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron
31: 791–807.
32. Xian HQ, Werth K, Gottlieb DI (2005) Promoter analysis in ES cell-derived
neural cells. Biochem Biophys Res Commun 327: 155–162.
33. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins
suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115: 281–292.
34. Wichterle H, Lieberam I, Porter JA, Jessell TM (2002) Directed differentiation of
embryonic stem cells into motor neurons. Cell 110: 385–397.
35. Bouhon IA, Joannides A, Kato H, Chandran S, Allen ND (2006) Embryonic
stem cell-derived neural progenitors display temporal restriction to neural
patterning. Stem Cells 24: 1908–1913.
36. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and
MatInspector: new fast and versatile tools for detection of consensus matches in
nucleotide sequence data. Nucleic Acids Res 23: 4878–4884.
37. Loots GG, Ovcharenko I (2004) rVISTA 2.0: evolutionary analysis of
transcription factor binding sites. Nucleic Acids Res 32: W217–221.
38. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, et al. (2006)
Competing waves of oligodendrocytes in the forebrain and postnatal elimination
of an embryonic lineage. Nat Neurosci 9: 173–179.
39. Kretzschmar M, Liu F, Hata A, Doody J, Massague J (1997) The TGF-beta
family mediator Smad1 is phosphorylated directly and activated functionally by
the BMP receptor kinase. Genes Dev 11: 984–995.
40. Spagnoli FM, Hemmati-Brivanlou A (2006) Guiding embryonic stem cells
towards differentiation: lessons from molecular embryology. Curr Opin Genet
Dev 16: 469–475.
41. Loebel DA, Watson CM, De Young RA, Tam PP (2003) Lineage choice and
differentiation in mouse embryos and embryonic stem cells. Dev Biol 264: 1–14.
42. Stavridis MP, Smith AG (2003) Neural differentiation of mouse embryonic stem
cells. Biochem Soc Trans 31: 45–49.
43. Keller G (2005) Embryonic stem cell differentiation: emergence of a new era in
biology and medicine. Genes Dev 19: 1129–1155.
44. Colak D, Mori T, Brill MS, Pfeifer A, Falk S, et al. (2008) Adult neurogenesis
requires Smad4-mediated bone morphogenic protein signaling in stem cells.
J Neurosci 28: 434–446.
45. Murtaugh LC, Zeng L, Chyung JH, Lassar AB (2001) The chick transcriptional
repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial
chondrogenesis. Dev Cell 1: 411–422.
46. Kim DW, Lassar AB (2003) Smad-dependent recruitment of a histone
deacetylase/Sin3A complex modulates the bone morphogenetic protein-
dependent transcriptional repressor activity of Nkx3.2. Mol Cell Biol 23:
8704–8717.
FGF and BMP Signalling in OPCs
PLoS ONE | www.plosone.org 8 August 2008 | Volume 3 | Issue 8 | e2863
